Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients. [electronic resource]
Producer: 20050711Description: 9-18 p. digitalISSN:- 0251-1649
- Adult
- Antibodies, Monoclonal -- administration & dosage
- Antigens, CD
- Antirheumatic Agents -- adverse effects
- Arthritis, Rheumatoid -- blood
- CD11c Antigen -- biosynthesis
- Dendritic Cells -- drug effects
- Drug Therapy, Combination
- Female
- Flow Cytometry
- Humans
- Immunoglobulins -- biosynthesis
- Infliximab
- Male
- Membrane Glycoproteins -- biosynthesis
- Methotrexate -- administration & dosage
- Middle Aged
- Phenotype
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- CD83 Antigen
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.